Nut Midline Carcinoma

• CLINICAL_TRIALS trial_result · 2018-11-05
  Clinical Trial Update: A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) [Phase 1]

  Phase 1 dose exploration study of birabresib (MK-8628) in selected advanced solid tumors (NMC, TNBC) was terminated; results posted in 2018.

• CLINICAL_TRIALS trial_result · 2018-10-01
  Clinical Trial Update: A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) [Phase 1]

  Phase 1 dose-finding study of birabresib (MK-8628), a BET inhibitor, completed with results posted in 2018 for selected advanced solid tumor…